Self-myofascial Release With Foam Roller in Patients With Hemophilic Ankle Arthropathy
Keywords
Abstract
Dates
| Last Verified: | 12/31/2019 |
| First Submitted: | 04/10/2019 |
| Estimated Enrollment Submitted: | 04/10/2019 |
| First Posted: | 04/15/2019 |
| Last Update Submitted: | 01/22/2020 |
| Last Update Posted: | 01/26/2020 |
| Actual Study Start Date: | 02/01/2020 |
| Estimated Primary Completion Date: | 06/25/2020 |
| Estimated Study Completion Date: | 12/14/2020 |
Condition or disease
Intervention/treatment
Other: Self-myofascial release
Phase
Arm Groups
| Arm | Intervention/treatment |
|---|---|
| Experimental: Self-myofascial release Each session will last approximately 15 minutes, with five physiotherapy sessions taking place over a period of 3 months. The Self-Myofascial release protocol for the lower limbs using a Foam Roller and and Solid Ball Massage, adapted to patients with hemophilic ankle arthropathy will include 11 exercises that must be administered bilaterally. A mobile application will be developed where each patient will be able to observe the exercises to be carried out. | Other: Self-myofascial release The Self-Myofascial release protocol for the lower limbs using a Foam Roller will include: Self-Myofascial release of the plantar region using and Solid Ball Massage; release of the myofascial components of the back of the leg using a Foam Roller; release of the myofascial components of the anterior part of the leg using a Foam Roller; release of myofascial components of the hamstring region using a Foam Roller; release of the myofascial components of the adductor muscles using a Solid Ball Massage in a sitting position; release of the myofascial components of the abductor muscles using a Foam Roller in lateral decubitus; and release of the myofascial components of the pelvitrochanteric muscles using a Foam Roller in a sitting position. |
| No Intervention: Control Patients included in the control group will not receive any physiotherapy intervention. They will continue with their routine prior to the beginning of the study. |
Eligibility Criteria
| Ages Eligible for Study | 18 Years To 18 Years |
| Sexes Eligible for Study | Male |
| Accepts Healthy Volunteers | Yes |
| Criteria | Inclusion Criteria: - Patients diagnosed with hemophilia A and B disease. - Over 18 years. - Diagnosed with hemophilic arthropathy of the ankle (by clinical assessment with the Hemophilia Joint Health Score). - On prophylactic or on demand treatment with FVIII / FIX concentrates. Exclusion Criteria: - Patients without ambulation ability. - Patients with inhibitors (antibodies to FVIII or FIX). - Patients with neurological or cognitive alterations that impede the comprehension of the questionnaires and physical tests. - Not signed the informed consent document. |
Outcome
Primary Outcome Measures
1. Change from baseline ankle joint pain after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
Secondary Outcome Measures
1. Change from baseline ankle joint pain after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
2. Change from baseline lower limb functionality after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
3. Change from baseline range of motion of ankle after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
4. Change from baseline muscle strength after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
5. Change from baseline muscle flexibility after treatment and at 3 months [Screening visit, within the first seven days after treatment and after three months follow-up visit]
